These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 31571136)

  • 61. High chronic nephropathy detection yield in CKD subjects identified by the combination of albuminuria and estimated GFR.
    Gambaro G; Bonfante L; Abaterusso C; Gemelli A; Ferraro PM; Marchesini S; De Conti G; D'Angelo A; Lupo A
    Nephrol Dial Transplant; 2012 Feb; 27(2):746-51. PubMed ID: 21737518
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Precision medicine in diabetic nephropathy and chronic kidney disease.
    Fliser D; Wanner C
    Nephrol Dial Transplant; 2021 Jun; 36(Suppl 2):10-13. PubMed ID: 34153982
    [TBL] [Abstract][Full Text] [Related]  

  • 63. First-year estimated glomerular filtration rate variability after pre-end-stage renal disease program enrollment and adverse outcomes of chronic kidney disease.
    Tsai CW; Huang HC; Chiang HY; Chung CW; Chiu HT; Liang CC; Yu T; Kuo CC
    Nephrol Dial Transplant; 2019 Dec; 34(12):2066-2078. PubMed ID: 29982714
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effect of model selection on cost-effectiveness research: a comparison of kidney function-based microsimulation and disease grade-based microsimulation in chronic kidney disease modeling.
    Hiragi S; Tamura H; Goto R; Kuroda T
    BMC Med Inform Decis Mak; 2018 Nov; 18(1):94. PubMed ID: 30413200
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association of Serum Ig Free Light Chains with Mortality and ESRD among Patients with Nondialysis-Dependent CKD.
    Ritchie J; Assi LK; Burmeister A; Hoefield R; Cockwell P; Kalra PA
    Clin J Am Soc Nephrol; 2015 May; 10(5):740-9. PubMed ID: 25825483
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cost-effectiveness of irbesartan in diabetic nephropathy: a systematic review of published studies.
    Palmer AJ; Tucker DM; Valentine WJ; Roze S; Gabriel S; Cordonnier DJ
    Nephrol Dial Transplant; 2005 Jun; 20(6):1103-9. PubMed ID: 15855214
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Combined diabetes-renal multifactorial intervention in patients with advanced diabetic nephropathy: Proof-of-concept.
    Fogelfeld L; Hart P; Miernik J; Ko J; Calvin D; Tahsin B; Adhami A; Mehrotra R; Fogg L
    J Diabetes Complications; 2017 Mar; 31(3):624-630. PubMed ID: 28041817
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Large kidneys predict poor renal outcome in subjects with diabetes and chronic kidney disease.
    Rigalleau V; Garcia M; Lasseur C; Laurent F; Montaudon M; Raffaitin C; Barthe N; Beauvieux MC; Vendrely B; Chauveau P; Combe C; Gin H
    BMC Nephrol; 2010 Mar; 11():3. PubMed ID: 20199663
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Filtration Markers as Predictors of ESRD and Mortality: Individual Participant Data Meta-Analysis.
    Inker LA; Coresh J; Sang Y; Hsu CY; Foster MC; Eckfeldt JH; Karger AB; Nelson RG; Liu X; Sarnak M; Appel LJ; Grams M; Xie D; Kimmel PL; Feldman H; Ramachandran V; Levey AS;
    Clin J Am Soc Nephrol; 2017 Jan; 12(1):69-78. PubMed ID: 28062677
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Abrupt Decline in Kidney Function Before Initiating Hemodialysis and All-Cause Mortality: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Hsu RK; Chai B; Roy JA; Anderson AH; Bansal N; Feldman HI; Go AS; He J; Horwitz EJ; Kusek JW; Lash JP; Ojo A; Sondheimer JH; Townsend RR; Zhan M; Hsu CY;
    Am J Kidney Dis; 2016 Aug; 68(2):193-202. PubMed ID: 26830447
    [TBL] [Abstract][Full Text] [Related]  

  • 72. KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methods.
    Oh KH; Park SK; Park HC; Chin HJ; Chae DW; Choi KH; Han SH; Yoo TH; Lee K; Kim YS; Chung W; Hwang YH; Kim SW; Kim YH; Kang SW; Park BJ; Lee J; Ahn C;
    BMC Nephrol; 2014 May; 15():80. PubMed ID: 24884708
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
    Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
    BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cardiovascular risk factors in CKD associate with both ESRD and mortality.
    Muntner P; Judd SE; Gao L; Gutiérrez OM; Rizk DV; McClellan W; Cushman M; Warnock DG
    J Am Soc Nephrol; 2013 Jun; 24(7):1159-65. PubMed ID: 23704285
    [TBL] [Abstract][Full Text] [Related]  

  • 75. FINE-CKD model to evaluate economic value of finerenone in patients with chronic kidney disease and type 2 diabetes.
    Pochopień MT; Cherney DZI; Folkerts K; Levy P; Millier A; Morris S; Roy-Chaudhury P; Sullivan SD; Mernagh P
    Am J Manag Care; 2021 Dec; 27(20 Suppl):S375-S382. PubMed ID: 34878755
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Antidiabetic SGLT-2 inhibitors prevent progression of chronic kidney disease].
    Heine GH
    Dtsch Med Wochenschr; 2020 Jun; 145(11):762-766. PubMed ID: 32492746
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Estimating the financial cost of chronic kidney disease to the NHS in England.
    Kerr M; Bray B; Medcalf J; O'Donoghue DJ; Matthews B
    Nephrol Dial Transplant; 2012 Oct; 27 Suppl 3(Suppl 3):iii73-80. PubMed ID: 22815543
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Systematic Review of Cost-Effectiveness Models in Type 1 Diabetes Mellitus.
    Henriksson M; Jindal R; Sternhufvud C; Bergenheim K; Sörstadius E; Willis M
    Pharmacoeconomics; 2016 Jun; 34(6):569-85. PubMed ID: 26792792
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long-Term and Interactive Effects of Pay-For-Performance Interventions among Diabetic Nephropathy Patients at the Early Chronic Kidney Disease Stage.
    Liao PJ; Lin TY; Wang TC; Ting MK; Wu IW; Huang HT; Wang FC; Chang HC; Hsu KH
    Medicine (Baltimore); 2016 Apr; 95(14):e3282. PubMed ID: 27057892
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.